210 related articles for article (PubMed ID: 30767060)
1. Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1.
Chmielewski L; Bietenbeck M; Patrascu A; Rösch S; Sechtem U; Yilmaz A; Florian AR
Clin Res Cardiol; 2019 Aug; 108(8):857-867. PubMed ID: 30767060
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study.
Hermans MC; Faber CG; Bekkers SC; de Die-Smulders CE; Gerrits MM; Merkies IS; Snoep G; Pinto YM; Schalla S
J Cardiovasc Magn Reson; 2012 Jul; 14(1):48. PubMed ID: 22827830
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
4. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
[TBL] [Abstract][Full Text] [Related]
5. Structural and electrical cardiac abnormalities are prevalent in asymptomatic adults with myotonic dystrophy.
Choudhary P; Nandakumar R; Greig H; Broadhurst P; Dean J; Puranik R; Celermajer DS; Hillis GS
Heart; 2016 Sep; 102(18):1472-8. PubMed ID: 27164920
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
7. Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies.
Peretto G; Sala S; Lazzeroni D; Palmisano A; Gigli L; Esposito A; De Cobelli F; Camici PG; Mazzone P; Basso C; Della Bella P
Heart Lung Circ; 2020 Sep; 29(9):1356-1365. PubMed ID: 32299760
[TBL] [Abstract][Full Text] [Related]
8. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients.
Florian A; Ludwig A; Engelen M; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2014 Sep; 16(1):81. PubMed ID: 25315351
[TBL] [Abstract][Full Text] [Related]
11. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
[TBL] [Abstract][Full Text] [Related]
12. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
[TBL] [Abstract][Full Text] [Related]
14. Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy.
Leali M; Aimo A; Ricci G; Torri F; Todiere G; Vergaro G; Grigoratos C; Giannoni A; Aquaro GD; Siciliano G; Emdin M; Passino C; Barison A
J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):340-347. PubMed ID: 37129928
[TBL] [Abstract][Full Text] [Related]
15. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation.
Suksaranjit P; McGann CJ; Akoum N; Biskupiak J; Stoddard GJ; Kholmovski EG; Navaravong L; Rassa A; Bieging E; Chang L; Haider I; Marrouche NF; Wilson BD
Am J Cardiol; 2016 Oct; 118(7):991-7. PubMed ID: 27553101
[TBL] [Abstract][Full Text] [Related]
17. Analyzing myocardial torsion based on tissue phase mapping cardiovascular magnetic resonance.
Chitiboi T; Schnell S; Collins J; Carr J; Chowdhary V; Honarmand AR; Hennemuth A; Linsen L; Hahn HK; Markl M
J Cardiovasc Magn Reson; 2016 Apr; 18():15. PubMed ID: 27062364
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cardiovascular magnetic resonance characteristics and clinical prognosis in left ventricular noncompaction patients with and without arrhythmia.
Zhou ZQ; He WC; Li X; Bai W; Huang W; Hou RL; Wang YN; Guo YK
BMC Cardiovasc Disord; 2022 Feb; 22(1):25. PubMed ID: 35109817
[TBL] [Abstract][Full Text] [Related]
19. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
[TBL] [Abstract][Full Text] [Related]
20. Cardiac magnetic resonance characteristics in young survivors of aborted sudden cardiac death.
Zaremba T; Brøndberg AK; Jensen HK; Kim WY
Eur J Radiol; 2018 Aug; 105():141-147. PubMed ID: 30017270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
